Publications by authors named "Karin Patocka"

Dupilumab is a monoclonal antibody against the IL-4 receptor alpha which has shown efficacy in T2 high severe asthmatics in phase 3 randomized controlled trials. The purpose of this real-life study is to demonstrate the real-life effectiveness of dupilumab in Austrian severe asthma patients. We retrospectively analyzed all patients receiving dupilumab at our severe asthma clinic.

View Article and Find Full Text PDF

Background: Mepolizumab was effective in several randomized clinical trials (RCTs) in patients with severe eosinophilic asthma, but evidence for symptom control in a real-world population is scarce.

Objective: To assess asthma symptom control, lung function, use of oral corticosteroids, and biomarkers after mepolizumab initiation in real-world clinical practice.

Methods: Thirty-five adult patients with severe eosinophilic asthma and inadequate asthma symptom control, including former smokers and patients with cardiac disease, were enrolled in a prospective single-arm real-world study.

View Article and Find Full Text PDF

Introduction: Only little is known about COVID-19 in patients with asthma. There is no data on COVID-19 in patients with severe asthma or patients with asthma who are treated with monoclonal antibodies.

Case Study: Here, we present the case of a severe eosinophilic asthmatic in whom benralizumab treatment, an anti-IL-5R monoclonal antibody, was initiated 2 years ago.

View Article and Find Full Text PDF

Objectives: Relative body weight is not only an important indicator for health and reproductive condition, but also subject to stereotypes and stigmatization. It can be reliably assessed from adult faces alone, yet the facial correlates, especially in adolescents, remain largely unidentified. This study was designed to determine the facial features of adolescent girls that change with body fat proportion using a modern, comprehensive technique for shape analysis.

View Article and Find Full Text PDF